I am the safety officer for our clinical trial and I think we should halt enrollment based on adverse events but the principal investigator disagrees and says I am being overcautious.
More people experience this than they realize.
Professional disagreement about acceptable risk creates situations where patient welfare depends on who has final authority.
“Where Are You with Science — Biotech & Pharmaceutical R&D?”
Peri can explain why this happens, help you decide if this is the right situation for you, and point toward the right journey or coach.
If this sounds familiar, the Library can help you find the bigger picture.